NASDAQ
Immunome, Inc. (IMNM) has a current ratio of 14.69x as of Tuesday, May 26, 2026. This represents a 199.49% increase compared to its 12-month average of 4.90x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.